Skip to main content
. 2016 Feb 23;7(14):18135–18145. doi: 10.18632/oncotarget.7636

Table 3. Multivariate subgroup analyses for OS from SRT in NSCLC.

Parameters HR 95% CI p values
Interval time (< 13.63 months vs. ≥ 13.63 months) 0.256 0.083-0.791 0.018
PTV volume (< 15.33 mL vs. ≥ 15.33 mL) 3.656 1.348-9.913 0.011
CT after SRT (yes vs. no) 1.549 0.559-4.008 0.367

Abbreviations: OS: overall survival; NSCLC: non-small cell lung cancer; HR: hazard ratio; CI: confidence interval; SRT: stereotactic radiation therapy; PTV: planning target volume; CT: chemotherapy.